Skip to main content
Premium Trial:

Request an Annual Quote

Coda Closes $7M VC Round, Will Use Cash for Biofuel Initiative and Rx Demo

NEW YORK (GenomeWeb News) — Coda Genomics has pocketed a $7 million Series C round of private equity financing and plans to use the cash to fund and manage growth, particularly in its collaborations with pharmaceutical companies, the company said today.
 
Coda CEO Robert Molinari said the financing will push growth in “several opportunistic areas,” including translational engineering, funding a biofuel enzyme initiative with the University of California, Irvine, and developing a therapeutic candidate demonstration project.
 
Leading the round was OVP Venture Partners, along with current investors Monitor Ventures, Tech Coast Angels, and Life Science Angels.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.